Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

UroTrials GmbH

Germany Sedanstrasse 15, Zellerau, 97082 Wuerzburg, Germany

About the sponsor

UroTrials GmbH focuses on metastatic castrate-sensitive prostate cancer, targeting advanced disease management.

  • Androgen receptor pathway inhibition
  • Androgen receptor degradation
  • Optimization of PSA response

The program integrates androgen deprivation therapy with emerging agents to enhance treatment outcomes.

About Specializations

UroTrials GmbH runs clinical trials in conditions such as Hormone-dependent prostate cancer, Prostate cancer metastatic, Prostate cancer, Prostate cancer stage IV, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Hormone-dependent prostate cancer+3

Not yet recruiting

BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986365
  • Sponsor:AIO-Studien gGmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.